Target- |
MechanismHistone methyltransferases inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with MercaChem Holding BV
0 Patents (Medical) associated with MercaChem Holding BV
100 Deals associated with MercaChem Holding BV
100 Translational Medicine associated with MercaChem Holding BV